Anti-epha2 antibodies as a cancer diagnostic

Details for Australian Patent Application No. 2007202091 (hide)

International Classifications

Event Publications

24 May 2007 Complete Application Filed

31 May 2007 Application Open to Public Inspection

Published as AU-A-2007202091

28 April 2011 Assignment before Grant

The University of North Carolina at Chapel Hill; Glaxo Group Limited; Purdue Research Foundation The application has been assigned to Purdue Research Foundation

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.